Free Trial

Avadel Pharmaceuticals (AVDL) SEC Filings & 10K Form

Avadel Pharmaceuticals logo
$9.18 -0.14 (-1.50%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$9.20 +0.02 (+0.16%)
As of 06/20/2025 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Avadel Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/18/2025
6:01 AM
Avadel Pharmaceuticals (Filer)
Form DEF 14A
06/18/2025
6:03 AM
Avadel Pharmaceuticals (Filer)
Form DEFA14A
06/18/2025
6:05 AM
Avadel Pharmaceuticals (Filer)
Form ARS
06/05/2025
6:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:00 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/13/2025
5:00 PM
Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/13/2025
5:01 PM
Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:22 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
8:20 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
1:59 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
2:01 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
3:45 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
8:16 AM
Avadel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:09 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
10:55 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
01/28/2025
3:22 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:22 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:24 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:18 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:15 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:20 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:13 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:14 PM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:02 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:50 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
5:10 AM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/13/2024
4:58 PM
Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G/A
11/12/2024
6:06 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
9:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:18 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:01 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
8:25 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:12 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:31 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
08/01/2024
3:32 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:35 PM
Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:36 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:37 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:38 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:12 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVDL) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners